Respire_final-01
  • CORPORATE
    • Company Overview
    • Company Management
    • Board of Directors
    • Scientific Team Leaders
    • Social Media Guidelines
  • NEUROTRANSMISSION
  • PHARMACEUTICAL CANNABINOIDS
    • Background
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • NEUROMODULATORS
    • Ampakines
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
      • Autism Spectrum Disorder (ASD)
    • GABAkines
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

Author: j3ff1

Home Articles Posted by j3ff1 (Page 3)
82 posts, 0 comments

1/3/2019 – RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors

January 3, 2019j3ff1
Read More

12/10/2018 – RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit,
December 10 – 12, 2018

December 10, 2018j3ff1
Read More

09/10/18 – RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.

September 10, 2018j3ff1
Read More

07/25/2018 – RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data: Effects of Chronic Systemic Low-impact Ampakine Treatment on Neurotrophin Expression in Rat Brain

July 25, 2018j3ff1
Read More

06/19/2018 – RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso

June 19, 2018j3ff1
Read More

06/19/2018 – RespireRx Pharmaceuticals Inc. Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.

June 19, 2018j3ff1
Read More

01/09/2018 – RespireRx presentation at Biotech Showcase 2018

January 8, 2018j3ff1
Read More

RespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase 2018

January 8, 2018j3ff1
Read More

RespireRx Pharmaceuticals Publishes Scientific Evidence Demonstrating CX717 Neurobiological Safety

December 18, 2017j3ff1
Read More

RespireRx Announces Debt Forgiveness for Past Due Cash Compensation

December 15, 2017j3ff1
Read More

Posts navigation

< 1 2 3 4 5 6 … 9 >

Neurotransmission

  • Neurotransmission
©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.